MedPath

anthanum carbonate impacts on calcification regulating factors in chronic kidney disease

Phase 4
Conditions
Outpatients with chronic kidney disease stage 3-5 in department of medicine, Kidney Center of Tokyo Women&#39
s Medical University
Registration Number
JPRN-UMIN000013978
Lead Sponsor
Department of Medicine, Kidney Center, Tokyo Women's Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who have a contraindication that is shown in the product documents of lanthanum carbonate or calcium carbonate. 2)Patients with malignant diseases or the possibility of maignant diseases of entry. 3)Patients with a past history of renal transplantation. 4)Pregnant women or women with possibility of pregnancy. 5)Patients who made a judgmental decision as an inadequate patient by the principal investigator

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath